Note1 Sept 2022
Working in partnership with hospitals on discharge reviews to involve people in their care packages
Note1 Sept 2022
Complaints reviewed thoroughly with written outcomes communicated to complainants
Note1 Sept 2022
Registered manager approachable; people felt comfortable raising concerns and being listened to
Note1 Sept 2022
Appropriate infection prevention and control procedures, with PPE worn in line with guidance
Note1 Sept 2022
Care plans and risk assessments accessible to staff via mobile devices with current information
Note1 Sept 2022
Electronic system used to monitor deployment of staff and alert to late calls
Note1 Sept 2022
Staff felt staffing levels had improved and there were always enough staff to support people safely
Note1 Sept 2022
Staff completed safeguarding training and were confident on how to report concerns
Note1 Sept 2022
Registered manager took immediate action to strengthen medicines recording when issues were raised
minorrecord_keeping1 Sept 2022
a risk assessment was missing on the day of the inspection relating to a staff member, in addition to reasons for some staff leaving previous roles was not detailed.
moderatestaff_competency1 Sept 2022
inspection findings identified the need for a greater focus on the recording processes relating to supporting people with their medicines.
moderatemissed_or_late_visits1 Sept 2022
Not all people were clear on who would be supporting them and when. A person told us, 'The time varies (of the calls), we used to get a rota but we don't now'.
moderaterecord_keeping1 Sept 2022
Care plans required greater detail where people would sometimes self-administer their own medicines, or when people refused their medicines.
criticalgovernance1 Sept 2022
Systems were not robust enough to demonstrate medicines were effectively managed. This placed people at risk of harm. This was a repeated breach of regulation 17 (Good Governance).
criticalmedication_management1 Sept 2022
Documentation did not demonstrate that medicated patches were applied in line with manufacture's guidance. Staff were not recording the location of the application or removal of the transdermal patch.
criticalmedication_management1 Sept 2022
Medicines oversight was not robust. We identified examples where the electronic medicines administration record (MAR) had not been completed.